• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3,5-二碘-L-甲状腺原氨酸诱导人肝癌(Hepg2)细胞中SREBP-1蛋白水解切割受阻及细胞凋亡。

3,5-Diiodo-l-thyronine induces SREBP-1 proteolytic cleavage block and apoptosis in human hepatoma (Hepg2) cells.

作者信息

Rochira Alessio, Damiano Fabrizio, Marsigliante Santo, Gnoni Gabriele V, Siculella Luisa

机构信息

Laboratory of Biochemistry and Molecular Biology, Department of Biological and Environmental Science and Technologies, University of Salento, Via Prov. le Lecce-Monteroni, Lecce 73100, Italy.

出版信息

Biochim Biophys Acta. 2013 Dec;1831(12):1679-89. doi: 10.1016/j.bbalip.2013.08.003. Epub 2013 Aug 13.

DOI:10.1016/j.bbalip.2013.08.003
PMID:23948263
Abstract

Thyroid hormone 3,5,3'-triiodo-l-thyronine (T3) is known to affect cell metabolism through both the genomic and non-genomic actions. Recently, we demonstrated in HepG2 cells that T3 controls the expression of SREBP-1, a transcription factor involved in the regulation of lipogenic genes. This occurs by activation of a cap-independent translation mechanism of its mRNA. Such a process is dependent on non-genomic activation of both MAPK/ERK and PI3K/Akt pathways. The physiological role of 3,5-diiodo-l-thyronine (T2), previously considered only as a T3 catabolite, is of growing interest. Evidences have been reported that T2 rapidly affects some metabolic pathways through non-genomic mechanisms. Here, we show that T2, unlike T3, determines the block of proteolytic cleavage of SREBP-1 in HepG2 cells, without affecting its expression at the transcriptional or translational level. Consequently, Fatty Acid Synthase expression is reduced. T2 effects depend on the concurrent activation of MAPKs ERK and p38, of Akt and PKC-δ pathways. Upon the activation of these signals, apoptosis of HepG2 cells seems to occur, starting at 12h of T2 treatment. PKC-δ appears to act as a switch between p38 activation and Akt suppression, suggesting that this PKC may function as a controller in the balance of pro-apoptotic (p38) and anti-apoptotic (Akt) signals in HepG2 cells.

摘要

甲状腺激素3,5,3'-三碘-L-甲状腺原氨酸(T3)已知可通过基因组和非基因组作用影响细胞代谢。最近,我们在HepG2细胞中证明,T3控制SREBP-1的表达,SREBP-1是一种参与脂肪生成基因调控的转录因子。这是通过激活其mRNA的非帽依赖性翻译机制实现的。这样的过程依赖于MAPK/ERK和PI3K/Akt途径的非基因组激活。3,5-二碘-L-甲状腺原氨酸(T2)的生理作用越来越受到关注,T2以前仅被视为T3的分解代谢产物。已有报道表明,T2通过非基因组机制迅速影响一些代谢途径。在这里,我们表明,与T3不同,T2可导致HepG2细胞中SREBP-1的蛋白水解切割受阻,而不影响其在转录或翻译水平的表达。因此,脂肪酸合酶的表达降低。T2的作用取决于MAPKs ERK和p38、Akt和PKC-δ途径的同时激活。在这些信号激活后,HepG2细胞的凋亡似乎在T2处理12小时后开始发生。PKC-δ似乎在p38激活和Akt抑制之间起开关作用,表明该PKC可能在HepG2细胞中促凋亡(p38)和抗凋亡(Akt)信号的平衡中起控制器的作用。

相似文献

1
3,5-Diiodo-l-thyronine induces SREBP-1 proteolytic cleavage block and apoptosis in human hepatoma (Hepg2) cells.3,5-二碘-L-甲状腺原氨酸诱导人肝癌(Hepg2)细胞中SREBP-1蛋白水解切割受阻及细胞凋亡。
Biochim Biophys Acta. 2013 Dec;1831(12):1679-89. doi: 10.1016/j.bbalip.2013.08.003. Epub 2013 Aug 13.
2
3,5,3'triiodo-L-thyronine induces SREBP-1 expression by non-genomic actions in human HEP G2 cells.3,5,3'-三碘-L-甲状腺素通过非基因组作用诱导人 HEP G2 细胞中 SREBP-1 的表达。
J Cell Physiol. 2012 Jun;227(6):2388-97. doi: 10.1002/jcp.22974.
3
3,5-diiodo-L-thyronine increases de novo lipogenesis in liver from hypothyroid rats by SREBP-1 and ChREBP-mediated transcriptional mechanisms.3,5-二碘-L-甲状腺原氨酸通过 SREBP-1 和 ChREBP 介导的转录机制增加甲状腺功能减退大鼠肝脏中的从头脂肪生成。
IUBMB Life. 2019 Jul;71(7):863-872. doi: 10.1002/iub.2014. Epub 2019 Feb 1.
4
Lipid accumulation stimulates the cap-independent translation of SREBP-1a mRNA by promoting hnRNP A1 binding to its 5'-UTR in a cellular model of hepatic steatosis.在肝脂肪变性细胞模型中,脂质蓄积通过促进hnRNP A1与SREBP-1a mRNA的5'-UTR结合,刺激其不依赖帽结构的翻译。
Biochim Biophys Acta. 2016 May;1861(5):471-81. doi: 10.1016/j.bbalip.2016.02.003. Epub 2016 Feb 8.
5
Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.二十二碳六烯酸通过抑制人乳腺癌 MCF-7 细胞系中 pAkt 信号通路降低固醇调节元件结合蛋白-1 和脂肪酸合酶的表达,从而抑制细胞增殖。
BMC Cancer. 2017 Dec 28;17(1):890. doi: 10.1186/s12885-017-3936-7.
6
Phosphorylation of sterol regulatory element-binding protein (SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism and the secretome of human liver cell line HepG2.p38激酶、细胞外信号调节激酶(ERK)和c-Jun氨基末端激酶(JNK)对固醇调节元件结合蛋白(SREBP)-1c的磷酸化作用会影响人肝癌细胞系HepG2的脂质代谢和分泌组。
Arch Physiol Biochem. 2014 Dec;120(5):216-27. doi: 10.3109/13813455.2014.973418.
7
Prolonged high-glucose exposure decreased SREBP-1/FASN/ACC in Schwann cells of diabetic mice via blocking PI3K/Akt pathway.长期高糖暴露通过阻断 PI3K/Akt 通路降低糖尿病小鼠雪旺细胞中的 SREBP-1/FASN/ACC。
J Cell Biochem. 2019 Apr;120(4):5777-5789. doi: 10.1002/jcb.27864. Epub 2018 Oct 26.
8
Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.吲哚美辛通过激活丝裂原活化蛋白激酶和AKT诱导786-O肾癌细胞凋亡。
Eur J Pharmacol. 2007 Jun 1;563(1-3):49-60. doi: 10.1016/j.ejphar.2007.01.071. Epub 2007 Feb 8.
9
Effect of exercise and insulin on SREBP-1c expression in human skeletal muscle: potential roles for the ERK1/2 and Akt signalling pathways.运动和胰岛素对人骨骼肌中SREBP-1c表达的影响:细胞外信号调节激酶1/2(ERK1/2)和蛋白激酶B(Akt)信号通路的潜在作用
Biochem Soc Trans. 2007 Nov;35(Pt 5):1310-1. doi: 10.1042/BST0351310.
10
Intracellular and plasma membrane-initiated pathways involved in the [Ca2+]i elevations induced by iodothyronines (T3 and T2) in pituitary GH3 cells.甲状腺激素(T3 和 T2)在垂体 GH3 细胞中诱导 [Ca2+]i 升高所涉及的细胞内和质膜起始途径。
Am J Physiol Endocrinol Metab. 2012 Jun 1;302(11):E1419-30. doi: 10.1152/ajpendo.00389.2011. Epub 2012 Mar 13.

引用本文的文献

1
Regulation and targeting of SREBP-1 in hepatocellular carcinoma.SREBP-1 在肝细胞癌中的调控和靶向治疗。
Cancer Metastasis Rev. 2024 Jun;43(2):673-708. doi: 10.1007/s10555-023-10156-5. Epub 2023 Dec 1.
2
CGF-HLC-I repaired the bone defect repair of the rabbits mandible through tight junction pathway.CGF-HLC-I通过紧密连接途径修复兔下颌骨缺损。
Front Bioeng Biotechnol. 2022 Sep 20;10:976499. doi: 10.3389/fbioe.2022.976499. eCollection 2022.
3
3,5-T2-an Endogenous Thyroid Hormone Metabolite as Promising Lead Substance in Anti-Steatotic Drug Development?
3,5-T2——一种内源性甲状腺激素代谢产物能否成为抗脂肪变性药物研发中颇具潜力的先导物质?
Metabolites. 2022 Jun 23;12(7):582. doi: 10.3390/metabo12070582.
4
Concentrated Growth Factors (CGF) Induce Osteogenic Differentiation in Human Bone Marrow Stem Cells.浓缩生长因子(CGF)诱导人骨髓干细胞向成骨分化。
Biology (Basel). 2020 Oct 30;9(11):370. doi: 10.3390/biology9110370.
5
Genomic and Non-Genomic Mechanisms of Action of Thyroid Hormones and Their Catabolite 3,5-Diiodo-L-Thyronine in Mammals.甲状腺激素及其代谢产物 3,5-二碘-L-甲状腺原氨酸在哺乳动物中的基因组和非基因组作用机制。
Int J Mol Sci. 2020 Jun 10;21(11):4140. doi: 10.3390/ijms21114140.
6
In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis.在脂肪变性细胞中,ATP-柠檬酸裂解酶 mRNA 通过一种帽非依赖性机制进行有效的翻译,有助于刺激从头合成脂肪。
Int J Mol Sci. 2020 Feb 11;21(4):1206. doi: 10.3390/ijms21041206.
7
Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists.非酒精性脂肪性肝病与高胆固醇血症:甲状腺激素、代谢物和激动剂的作用。
Thyroid. 2019 Sep;29(9):1173-1191. doi: 10.1089/thy.2018.0664.
8
Role of SREBPs in Liver Diseases: A Mini-review.固醇调节元件结合蛋白在肝脏疾病中的作用:一篇综述短文
J Clin Transl Hepatol. 2018 Sep 28;6(3):332-338. doi: 10.14218/JCTH.2017.00061. Epub 2018 May 4.
9
A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism.对甲状腺激素与脂质代谢之间关联的重新关注。
Front Endocrinol (Lausanne). 2018 Sep 3;9:511. doi: 10.3389/fendo.2018.00511. eCollection 2018.
10
3,5-Diiodothyronine: A Novel Thyroid Hormone Metabolite and Potent Modulator of Energy Metabolism.3,5-二碘甲腺原氨酸:一种新型甲状腺激素代谢产物及能量代谢的强效调节剂。
Front Endocrinol (Lausanne). 2018 Jul 25;9:427. doi: 10.3389/fendo.2018.00427. eCollection 2018.